Страна: Малайзия
Език: английски
Източник: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Adenosine
SANOFI-AVENTIS (MALAYSIA) SDN. BHD.
Adenosine
6Units Units
Famar Health Care Services Madrid S.A.U.
ADENOCOR ® INJECTION Adenosine QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 6mg of adenosine per 2ml (3mg/ml). For excipients, see List of Excipients PHARMACEUTICAL FORM Solution for injection Clear, colourless solution CLINICAL PARTICULARS Therapeutic indications R a p i d c o n v e r s i o n t o a n o r m a l s i n u s r h y t h m o f p a r o x y s m a l sup ra ven t ricula r tachyca rd ia s, in clud ing tho se asso cia ted with accessory by -pass tracts (Wolff -Parkinson -White Syndrome). Diagnostic Indications Aid to diagnosis of broad or narrow complex supraventricular tachycardias. Although Adenocor will not convert atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of AV conduction helps diagnosis of atrial activity. Sensitisation of i ntra -cavitary electrophysiological investigations. Posology and method of administration Adenocor is intended for hospital use only with mo nitoring and cardiorespiratory resuscitation equipment available for immediate use. Method of administration It should be administered by rapid IV bolus injection according to the ascending dosage schedule below. To be certain the solution reaches the systemic circulation administer either directly into a vein or into an IV line. If given into an IV line it should b e injected as proximally as possible, and followed by a rapid saline flush. Adenocor should only be used when facilities exist for cardiac monitoring. Patients who develop high -level AV block at a particular dose should not be given further dosage incremen ts. Posology Adult: Initial dose: 3mg given as a rapid intravenous bolus (over 2 seconds). Second dose: If the first dose does not result in elimination of the supraventricular tachycardia within 1 to 2 minutes, 6mg should be given also as a rapid intravenous bolus. Third dose: If the second dose does not result in elimination of the supraventricular tachycardia within 1 to 2 minutes. 12mg should be given also as a rapid intravenous bolus. Additional or higher doses Прочетете целия документ